Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis
- PMID: 37331733
- DOI: 10.1016/j.rdc.2023.03.006
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is an eosinophilic vasculitis that affects a variety of organ systems. Historically, glucocorticoids and a variety of other immunosuppressants were used to abrogate the inflammation and tissue injury associated with EGPA. The management of EGPA has evolved greatly during the last decade with the development of novel targeted therapeutics that have resulted in significantly improved outcomes for these patients, with many more novel targeted therapies emerging.
Keywords: ANCA-associated vasculitis; Anti-IL-5; Churg-Strauss; EGPA; Eosinophilia; Mepolizumab; Therapeutics.
Copyright © 2023 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical